Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.00005 GBP per share
-
Shares outstanding
-
25.8B
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
19.7K
-
Shares change
-
-1.65K
-
Total reported value, excl. options
-
$17K
-
Value change
-
-$1.76K
-
Number of buys
-
2
-
Number of sells
-
-4
-
Price
-
$0.86
Significant Holders of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) as of Q2 2025
6 filings reported holding BDRX - Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share as of Q2 2025.
Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7K shares
of 25.8B outstanding shares and own 0% of the company stock.
Largest 6 shareholders include GAMMA Investing LLC (11.9K shares), SBI Securities Co., Ltd. (5.67K shares), UBS Group AG (1.99K shares), RHUMBLINE ADVISERS (69 shares), CONTRAVISORY INVESTMENT MANAGEMENT, INC. (0 shares), and MORGAN STANLEY (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.